
    
      This is a prospective, randomized, blinded, controlled, multicenter study enrolling two
      consecutive cohorts of up to 80 patients each (Propel Mini cohort followed by Propel Nova
      cohort). The study patients will undergo implant placement on one side following ESS that
      includes bilateral frontal sinus surgery by traditional surgical technique or balloon
      dilation.
    
  